Institutional Review Board “Shopping” Gauged By FDA As It Ponders Reg
This article was originally published in The Gray Sheet
Executive Summary
FDA wants to determine whether promulgating regulations requiring sponsors and investigators to inform institutional review boards of prior reviews would affect overall IRB review times